Xynomic pharmaceuticals holdings, inc. (BCAC)
CashFlow / TTM
Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income

-

-

331

-

-

-

34

-41

-109

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account

-

-

1,248

-

-

-

562

341

172

0

0

0

Unrealized loss on marketable securities held in Trust Account

-

-

-2

-

-

-

-36

-17

3

0

0

0

Changes in operating assets and liabilities:
Prepaid expenses

-510

-531

-52

-62

369

414

67

89

108

0

0

0

Accounts payable and accrued expenses

-

-

112

-

-

-

115

78

54

0

0

0

Net cash used in operating activities

-3,189

-5,662

-749

-687

-6,702

-3,368

-443

-376

-339

0

0

0

CASH FLOWS FROM INVESTING ACTIVITIES:
Cash withdrawn from Trust Account

0

0

0

-

-

-

-

-

-

-

-

-

Investment of cash and securities held in Trust Account

-

-

-

-

-

-

-

-

-

-

-

0

Net cash (used in)/provided by investing activities

0

0

0

-

-

-

-

-

-

-

-

0

CASH FLOWS FROM FINANCING ACTIVITIES:
Repayment of advances from related parties

-

-

-

-

-

-

70

157

157

0

0

0

Proceeds from issuance of ordinary shares

-

-

-

-

-

-

0

25

25

0

0

0

Proceeds from sale of Units, net of underwriting discounts paid

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from sale of Private Units

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from sale of unit purchase option

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from promissory note - related party

-

-

-

-

-

-

70

71

71

0

0

0

Proceeds from promissory note - related party

-

-

0

-

-

-

-

-

-

-

-

0

Redemption of ordinary shares

-

-

0

-

-

-

-

-

-

-

-

-

Repayment of promissory note - related party

-

-

-

-

-

-

-

-

-

-

-

0

Payment of offering costs

-

-

-

-

-

-

174

-

-

-

0

0

Net cash provided by/(used in) financing activities

-76,989

-63,597

-54,567

600

18,767

5,336

62,409

62,172

62,472

0

0

0

NET INCREASE/(DECREASE) IN CASH

-16,816

-4,330

-139

-87

11,971

327

81

-88

248

0

0

0

NON-CASH INVESTMENT AND FINANCING ACTIVITIES
Change in value of ordinary shares subject to possible redemption

-

-

0

-

-

-

5

-

106

0

0

0

Conversion of promissory notes to convertible promissory notes

-

-

0

-

-

-

-

-

-

-

-

-

Accrued offering costs

-

-

-

-

-

-

0

-

-

-

0

0

Offering costs charged to additional paid in capital

-

-

-

-

-

-

-

-

-

-

-

0

Initial classification of ordinary shares subject to possible redemption

-

-

-

-

-

-

-

-

-

-

-

0

Payment of offering costs through advances from related party

-

-

-

-

-

-

-

-

-

-

-

0

Subscription receivable

-

-

-

-

-

-

-

-

-

-

-

0